Innera sro
Benešov 256 01
2 studies enrolling now · 3 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Heart Failure, Obesity, Overweight, Systemic Inflammation
Studies at this site
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity — Recruiting now
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Running, not enrolling